Response of neurotensin basal ganglia systems during extinction of methamphetamine self-administration in rat

Journal of Pharmacology and Experimental Therapeutics

Volumn 346, Issue 2, 2013, Pages 173-181

  Hanson, Glen R ^a   Hoonakker, Amanda J ^a   Robson, Christina M ^a   McFadden, Lisa M ^a   Frankel, Paul S ^a   Alburges, Mario E ^a  

^a UNIVERSITY OF UTAH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE; MECLINERTANT; METHAMPHETAMINE; N2 (2,6 DIAMINOHEXYL)LYSYLPROLYLTRYPTOPHYL 3 METHYLVALYLLEUCINE ETHYL ESTER; NEUROTENSIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BASAL GANGLION; BRAIN FUNCTION; BRAIN LEVEL; BRAIN REGION; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC SYSTEM; DRUG MECHANISM; DRUG RESPONSE; DRUG SELF ADMINISTRATION; FEEDBACK SYSTEM; GLOBUS PALLIDUS; INSTRUMENTAL CONDITIONING; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REINFORCEMENT; SIGNAL TRANSDUCTION;

ANIMALS; BASAL GANGLIA; CENTRAL NERVOUS SYSTEM STIMULANTS; CONDITIONING, OPERANT; EXTINCTION, PSYCHOLOGICAL; MALE; METHAMPHETAMINE; NEUROTENSIN; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D2; RECEPTORS, NEUROTENSIN; REWARD; SELF ADMINISTRATION;

EID: 84880400495     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.113.205310     Document Type: Article

References (35)

1. Adams DH, Hanson GR, and Keefe KA (2001) Differential effects of cocaine and methamphetamine on neurotensin/neuromedin N and preprotachykinin messenger RNA expression in unique regions of the striatum. Neuroscience 102:843-851.
2. Antonelli T, Tomasini MC, Fuxe K, Agnati LF, Tanganelli S, and Ferraro L (2007) Receptor-receptor interactions as studied with microdialysis. Focus on NTR/D2 interactions in the basal ganglia. J Neural Transm 114:105-113.
3. Baldessarini R (1996) Drugs and the treatment of psychiatric disorders, in Pharmacological Basis of Therapeutics (Hardman J and Limbird L eds) pp 399-459, McGraw Hill Publishers, New York.
4. Castel MN, Morino P, Frey P, Terenius L, and Hökfelt T (1993) Immunohistochemical evidence for a neurotensin striatonigral pathway in the rat brain. Neuroscience 55:833-847.
5. Castel MN, Morino P, Dagerlind A, and Hökfelt T (1994a) Up-regulation of neurotensin mRNA in the rat striatum after acute methamphetamine treatment. Eur J Neurosci 6:646-656.
6. Castel MN, Morino P, Nylander I, Terenius L, and Hökfelt T (1994b) Differential dopaminergic regulation of the neurotensin striatonigral and striatopallidal pathways in the rat. Eur J Pharmacol 262:1-10.
7. Dearry A, Gingrich JA, Falardeau P, Fremeau RT, Jr, Bates MD, and Caron MG (1990) Molecular cloning and expression of the gene for a human D1 dopamine receptor. Nature 347:72-76.
8. Ervin GN, Birkemo LS, Nemeroff CB, and Prange AJ, Jr (1981) Neurotensin blocks certain amphetamine-induced behaviours. Nature 291:73-76.
9. Feifel D, Melendez G, Murray RJ, Tina Tran DN, Rullan MA, and Shilling PD (2008) The reversal of amphetamine-induced locomotor activation by a selective neurotensin-1 receptor agonist does not exhibit tolerance. Psychopharmacology (Berl) 200:197-203.
10. Ferraro L, Tomasini MC, Fuxe K, Agnati LF, Mazza R, Tanganelli S, and Antonelli T (2007) Mesolimbic dopamine and cortico-accumbens glutamate afferents as major targets for the regulation of the ventral striato-pallidal GABA pathways by neurotensin peptides. Brain Res Brain Res Rev 55:144-154.
11. Frankel PS, Hoonakker AJ, Alburges ME, McDougall JW, McFadden LM, Fleckenstein AE, and Hanson GR (2011) Effect of methamphetamine self-administration on neurotensin systems of the basal ganglia. J Pharmacol Exp Ther 336:809-815.
12. Frankel PS, Hoonakker AJ, Hanson GR, Bush L, Keefe KA, and Alburges ME (2005) Differential neurotensin responses to low and high doses of methamphetamine in the terminal regions of striatal efferents. Eur J Pharmacol 522:47-54.
13. Fuchs RA, Evans KA, Ledford CC, Parker MP, Case JM, Mehta RH, and See RE (2005) The role of the dorsomedial prefrontal cortex, basolateral amygdala, and dorsal hippocampus in contextual reinstatement of cocaine seeking in rats. Neuropsychopharmacology 30:296-309.
14. Gerfen CR, Engber TM, Mahan LC, Susel Z, Chase TN, Monsma FJ, Jr, and Sibley DR (1990) D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science 250:1429-1432.
15. Hanson GR, Hoonakker AJ, Alburges ME, McFadden LM, Robson CM, and Frankel PS (2012) Response of limbic neurotensin systems to methamphetamine selfadministration. Neuroscience 203:99-107.
16. Hanson GR, Singh N, Merchant K, Johnson M, Bush L, and Gibb JW (1992) Responses of limbic and extrapyramidal NT systems to stimulants of abuse. Ann N Y Acad Sci 668:165-172.
17. Hanson GR, Smiley P, Johnson M, Letter A, Bush L, and Gibb JW (1989) Response by the neurotensin systems of the basal ganglia to cocaine treatment. Eur J Pharmacol 160:23-30.
18. Koob GF and Volkow ND (2010) Neurocircuitry of addiction. Neuropsychopharmacology 35:217-238.
19. Kuczenski R, Melega WP, Cho AK, and Segal DS (1997) Extracellular dopamine and amphetamine after systemic amphetamine administration: comparison to the behavioral response. J Pharmacol Exp Ther 282:591-596.
20. Letter AA, Merchant KM, Gibb JW, and Hanson GR (1987) Effect of methamphetamine on neurotensin concentrations in rat brain regions. J Pharmacol Exp Ther 241:443-447.
21. Liang Y, Boules M, Shaw AM, Williams K, Fredrickson P, and Richelson E (2008) Effect of a novel neurotensin analog, NT69L, on nicotine-induced alterations in monoamine levels in rat brain. Brain Res 1231:6-15.
22. Liang Y, Boules M, Li Z, Williams K, Miura T, Oliveros A, and Richelson E (2010) Hyperactivity of the dopaminergic system in NTS1 and NTS2 null mice. Neuropharmacology 58:1199-1205.
23. Merchant KM, Hanson GR, and Dorsa DM (1994) Induction of neurotensin and c-fos mRNA in distinct subregions of rat neostriatum after acute methamphetamine: comparison with acute haloperidol effects. J Pharmacol Exp Ther 269:806-812.
24. Merchant KM, Bush LG, Gibb JW, and Hanson GR (1989a) Dopamine D2 receptors exert tonic regulation over discrete neurotensin systems of the rat brain. Brain Res 500:21-29.
25. Merchant KM, Gibb JW, and Hanson GR (1989b) Role of dopamine D-1 and D-2 receptors in the regulation of neurotensin systems of the neostriatum and the nucleus accumbens. Eur J Pharmacol 160:409-412.
26. Meredith CW, Jaffe C, Ang-Lee K, and Saxon AJ (2005) Implications of chronic methamphetamine use: a literature review. Harv Rev Psychiatry 13:141-154.
27. Norman C, Beckett SR, Spicer CH, Ashton D, Langlois X, and Bennett GW (2008) Effects of chronic infusion of neurotensin and a neurotensin NT1 selective analogue PD149163 on amphetamine-induced hyperlocomotion. J Psychopharmacol 22: 300-307.
28. Paxinos P and Watson C (1982) The Rat Brain in Stereotaxic Coordinates, Academic Press, New York.
29. Pereira FC, Lourenço E, Milhazes N, Morgadinho T, Ribeiro CF, Ali SF, and Macedo TR (2006) Methamphetamine, morphine, and their combination: acute changes in striatal dopaminergic transmission evaluated by microdialysis in awake rats. Ann N Y Acad Sci 1074:160-173.
30. Schiffer WK, Liebling CN, Reiszel C, Hooker JM, Brodie JD, and Dewey SL (2009) Cue-induced dopamine release predicts cocaine preference: positron emission tomography studies in freely moving rodents. J Neurosci 29:6176-6185.
31. See RE, Elliott JC, and Feltenstein MW (2007) The role of dorsal vs ventral striatal pathways in cocaine-seeking behavior after prolonged abstinence in rats. Psychopharmacology (Berl) 194:321-331.
32. Torregrossa MM and Kalivas PW (2008) Neurotensin in the ventral pallidum increases extracellular gamma-aminobutyric acid and differentially affects cueand cocaine-primed reinstatement. J Pharmacol Exp Ther 325:556-566.
33. Wagstaff JD, Gibb JW, and Hanson GR (1996a) Microdialysis assessment of methamphetamine-induced changes in extracellular neurotensin in the striatum and nucleus accumbens. J Pharmacol Exp Ther 278:547-554.
34. Wagstaff JD, Gibb JW, and Hanson GR (1996b) Dopamine D2-receptors regulate neurotensin release from nucleus accumbens and striatum as measured by in vivo microdialysis. Brain Res 721:196-203.
35. Wagstaff JD, Bush LG, Gibb JW, and Hanson GR (1994) Endogenous neurotensin antagonizes methamphetamine-enhanced dopaminergic activity. Brain Res 665: 237-244.